World Diabetes Day 2026: What's it all about and how can you get involved?
World Diabetes Day takes place on 14th November. Find out why we celebrate it, what's happening in 2026 and how PWD, families...
KEEPING YOU IN THE LOOP
Libre Life Newsletter
News and stories from the latest edition. Independently written by a T1D community member. Not affiliated with any medtech provider.
Articles
-
Pinned
Libre Life Autumn 2026
· Samantha Hooper
Welcome to the Autumn edition of Libre Life, keeping you in the loop with the latest CGM, medtech and diabetes news. In 2026, several medtech companies have been restructuring their businesses, with some looking towards the bigger and potentially more...
A word from the Editor -
-
Dexcom Backlash: Agree to our terms or lose access to your glucose readings?
Dexcom users were furious after being confronted with app Ts&Cs demanding agreement before they could access glucose readings. The backlash over AI,...
-
New British CGM Sava aims to challenge FreeStyle Libre and Dexcom
British startup Sava Technologies is developing a new CGM using microsensors ten times shorter than conventional sensor filaments. Backed by $36 million...
-
Adding protein to breakfast could reduce glucose spikes in children with Type 1 diabetes
Could adding an egg or cheese to breakfast help prevent glucose spikes? New UK research involving children and teenagers with type 1...
-
For every £1 Diabetes UK received — Just 6½ p was committed to New Research
Diabetes UK received £43.8 million in 2025, but only 6½p in every £1 was committed to new research from its core funds....
-
What Diabetes UK doesn’t make clear about the £50 Million Fund for a Cure
From Redrow's cladding and fire-safety controversies to Conservative Party donations, discover the billionaire behind the £50 million search for a type 1...
-
Novo Nordisk becomes ‘Novo’ as diabetes giant rebrands for health market
Novo Nordisk is adopting the shorter name ‘Novo’ as part of a major global rebrand. Behind the new logo is a wider...
-
Once-weekly insulin for type 2 diabetes: NICE backs a very different kind of diabetes innovation
NICE has backed once-weekly insulin efsitora alfa, branded Onswik, for type 2 diabetes manangement. It could mean 313 fewer basal injections a...
Subscribe to Libre Life
Join our community for news updates and free resources. Support for all sensor wearers. No spam.
Find out more